(Q51480962)

English

Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.

scientific article published in February 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224000%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224000%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224000%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224000%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224000%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Choon Hee Chung

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224000%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Hyeong Jin Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224000%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Dae Jung Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224000%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

So Hun Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224000%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Moonsuk Nam

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224000%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Kwan Woo Lee

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224000%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Chung Mo Nam

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224000%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Hyun Chul Lee

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224000%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

1 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224000%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224000%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

66

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224000%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224000%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

282-289

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224000%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Predictive clinical parameters for therapeutic efficacy of rosiglitazone in Korean type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Influence of rosiglitazone treatment on beta-cell function in type 2 diabetes: evidence of an increased ability of glucose to entrain high-frequency insulin pulsatility

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Adiponectin: A novel adipokine linking adipocytes and vascular function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Functional IL-18 Is produced by primary pancreatic mouse islets and NIT-1 beta cells and participates in the progression towards destructive insulitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Clinical evidence of thiazolidinedione-induced improvement of pancreatic beta-cell function in patients with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Concentration of IL-2, IL-6, IL-8, IL-10 and TNF-alpha in children with acute lymphoblastic leukemia after cessation of chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

The 11482G >A polymorphism in the perilipin gene is associated with weight gain with rosiglitazone treatment in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Individual and combined effects of peroxisome proliferator-activated receptor and {gamma} agonists, fenofibrate and rosiglitazone, on biomarkers of lipid and glucose metabolism in healthy nondiabetic volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Long-term efficacy of triple oral therapy for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Interleukin-18: recent advances

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Interleukin-18 induces acute biphasic reduction in the levels of circulating leukocytes in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Effect of Troglitazone on B Cell Function, Insulin Sensitivity, and Glycemic Control in Subjects with Type 2 Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02723.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2006.02723.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224000%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17224000%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51480962&oldid=1512250661"